Replies to post #6038 on OWC Pharmaceutical Research Corp (OWCP)

[1234zxcv]

5*****post....I can see the big picture..$$$$$$$

[was GoldenDD]

Excellent DD ! Now I need more shares and sit tight until Nov 8th and walk out with $$$$$$$$

[skichic]

Study the other stock mentioned in this post and compare it to OWCP, a $130.00+ stock to a .07 cent stock, which one would you pick?? The financials of the $130.00 stock with the .07 cent stock and the potential of each. I believe OWCP has better financials and equal potential. What do you all think??

[cjstocksup]

OWCP should be a .50 plus stock just ahead IMO. OWCP an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced it signed an agreement for $300,000 with Medmar LLC ("Medmar").

According to the terms of the agreement:

The funds will be allocated to complete the development of the Company's proprietary psoriasis cream;

Medmar will have exclusive right to manufacture, produce, publicize, promote and market OWC's Licensed Products in any state in the U.S;

The loan is non-interest bearing and will be repaid from royalties generated by the sale of OWC licensed products.

More details:
Medmar has agreed to loan OCW Ltd a total of $300,000 (the “Loan”) on a non-interest bearing basis, with no conversion rights. Medmar will fund the Loan in six equal installments of $50,000 each, as follows: (i) 1st installment was released to OWC Ltd on September 22, 2016; (ii) 2nd installment on October 1, 2016; (iii) 3rd installment on November 1, 2016; (iv) 4th installment on December 1, 2016; (v) 5th installment on January 1, 2017; and (vi) 6th installment on February 1, 2017. The Loan, as noted above, bears no interest, is not convertible, is due in 36 months from the Effective Date, and repayment shall be made only by the set off of royalties payable by Medmar to OWC Ltd.

PR:https://finance.yahoo.com/news/owc-pharmaceutical-research-corp-signs-120000921.html

8k: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11614519 .

OWCP Looks to Bring Pharma-Grade Cannabis Therapeutics to Market!!!

There are many different companies active in the medical marijuana industry, but few of them are conducting clinical research trials in accord with the Helsinki Committee Institutional Review Board protocols. Most investors are familiar with GW Pharmaceuticals plc (NASDAQ: GWPH) and its Sativex® cannabinoid medicine for the treatment of multiple sclerosis symptoms and cancer pain indications, but OWC Pharmaceutical Research Corp. (OTCQB: OWCP) is a lesser known company operating in the burgeoning industry.

Based in Israel, an international tech and biotech hub, and the epicenter of medical cannabis research, the OWCP is conducting clinical trials of cannabis-based treatments for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder and migraines. The team is also working on several proprietary drug delivery mechanisms designed to provide consistent and reliable cannabinoid doses to patients more efficiently than smoking or consuming marijuana edibles.

Full Article below Please watch the interview: http://www.baystreet.ca/viewarticle.aspx?id=437873 .

99% of all CANNABIS RESEARCH IS BEING DONE IN ISREAL, OWCP IS AT THE EPICENTER OF THIS WORK


OWCP named one of top 20 Cannabis Stocks by Cannabis Investor Magazine!!!

Cannabis Investor Magazine June Top 20 Cannabis Stocks

OWCP made the list huge recognition we are sitting on a goldmine.

https://finance.yahoo.com/news/cannabis-investor-magazine-june-top-130000276.htm

http://www.owcpharma.com/

[cjstocksup]

OWCP should be a .50 plus stock just ahead IMO. OWCP an Israeli-based developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced it signed an agreement for $300,000 with Medmar LLC ("Medmar").

According to the terms of the agreement:

The funds will be allocated to complete the development of the Company's proprietary psoriasis cream;

Medmar will have exclusive right to manufacture, produce, publicize, promote and market OWC's Licensed Products in any state in the U.S;

The loan is non-interest bearing and will be repaid from royalties generated by the sale of OWC licensed products.

More details:
Medmar has agreed to loan OCW Ltd a total of $300,000 (the “Loan”) on a non-interest bearing basis, with no conversion rights. Medmar will fund the Loan in six equal installments of $50,000 each, as follows: (i) 1st installment was released to OWC Ltd on September 22, 2016; (ii) 2nd installment on October 1, 2016; (iii) 3rd installment on November 1, 2016; (iv) 4th installment on December 1, 2016; (v) 5th installment on January 1, 2017; and (vi) 6th installment on February 1, 2017. The Loan, as noted above, bears no interest, is not convertible, is due in 36 months from the Effective Date, and repayment shall be made only by the set off of royalties payable by Medmar to OWC Ltd.

PR:https://finance.yahoo.com/news/owc-pharmaceutical-research-corp-signs-120000921.html

8k: http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11614519 .

OWCP Looks to Bring Pharma-Grade Cannabis Therapeutics to Market!!!

There are many different companies active in the medical marijuana industry, but few of them are conducting clinical research trials in accord with the Helsinki Committee Institutional Review Board protocols. Most investors are familiar with GW Pharmaceuticals plc (NASDAQ: GWPH) and its Sativex® cannabinoid medicine for the treatment of multiple sclerosis symptoms and cancer pain indications, but OWC Pharmaceutical Research Corp. (OTCQB: OWCP) is a lesser known company operating in the burgeoning industry.

Based in Israel, an international tech and biotech hub, and the epicenter of medical cannabis research, the OWCP is conducting clinical trials of cannabis-based treatments for multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder and migraines. The team is also working on several proprietary drug delivery mechanisms designed to provide consistent and reliable cannabinoid doses to patients more efficiently than smoking or consuming marijuana edibles.

Full Article below Please watch the interview: http://www.baystreet.ca/viewarticle.aspx?id=437873 .

99% of all CANNABIS RESEARCH IS BEING DONE IN ISREAL, OWCP IS AT THE EPICENTER OF THIS WORK


OWCP named one of top 20 Cannabis Stocks by Cannabis Investor Magazine!!!

Cannabis Investor Magazine June Top 20 Cannabis Stocks

OWCP made the list huge recognition we are sitting on a goldmine.

https://finance.yahoo.com/news/cannabis-investor-magazine-june-top-130000276.htm

http://www.owcpharma.com/

[CreationGuru10]

Can't wait til that doesn't happen even tho I have shares. Just another wonderful ihub post w/o the details. 3000 dollars next week!

[goingUPagain]

I hope .50pps becomes reality for owcp or $1 pps...imo---owcp is far superior to other mj stocks for two reasons:

1. clinical trials and real, deep research of those products

2. low float and low debt...

owcp does not fake it to make it...jmho...

[High_Profits]

Up up and away

[High_Profits]

***MUST SEE OWCP Videos & Social Media UPDATED***


OWCP Board of Advisors - Jeffrey Friedland on One World Cannabis
http://www.cannabisfn.com/cfnvideo/?id=nVH1IOjO

OWCP - Executive Management
Dr. Yehuda Baruch, Dir. of Research & Regulatory Affairs and Dr. Alan Shackelford
http://tinyurl.com/gwe4lw4

OWC Pharma - CEO Ziv Turner
http://www.cannabisfn.com/cfnvideo/?id=sLXXiKPI

Report on Israel Cannabis Industry
https://www.facebook.com/CannaTech2015/videos/1578369659142955/

Jeffrey Friedland - Cannabis Expert - OWCP Board
Author of .. “MARIJUANA: The World's Most Misunderstood Plant”

- Medical Marijuana Conference

Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today and others
http://www.jeffreyfriedland.com/


Follow OWCP on Facebook and Twitter

FB
https://www.facebook.com/search/top/?q=owcpharma

TWITTER
https://twitter.com/OWCPharma

OWCP Website
http://www.owcpharma.com/

OWCP SEC Filings
http://www.owcpharma.com/investors/


OWCP PHARMA CONTACTS
http://www.owcpharma.com/contacts

In Israel:
Ziv Turner, Chief Executive Officer - One World Cannabis Ltd.
Email: [e-mail]
Tel: [phone]

In the United States:
Jeffrey Friedland
Email: [e-mail]
Tel: [phone]

OWCP #OWCP $OWCP

[High_Profits]

** Medical Marijuana Sales Skyrocket **

http://mjbizdaily.com/chart-california-medical-marijuana-sales-skyrocket-132-since-2010/